PT2380575E - Acetato de eslicarbazepina e utilização - Google Patents
Acetato de eslicarbazepina e utilização Download PDFInfo
- Publication number
- PT2380575E PT2380575E PT111744157T PT11174415T PT2380575E PT 2380575 E PT2380575 E PT 2380575E PT 111744157 T PT111744157 T PT 111744157T PT 11174415 T PT11174415 T PT 11174415T PT 2380575 E PT2380575 E PT 2380575E
- Authority
- PT
- Portugal
- Prior art keywords
- eslicarbazepine acetate
- eslicarbazepine
- acetate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/PT2005/000006 WO2006121363A1 (en) | 2005-05-06 | 2005-05-06 | Eslicarbazepine acetate and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2380575E true PT2380575E (pt) | 2015-06-17 |
Family
ID=35464075
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT111744033T PT2380573E (pt) | 2005-05-06 | 2005-05-06 | Acetato de eslicarbazepina e métodos de utilização |
PT111744157T PT2380575E (pt) | 2005-05-06 | 2005-05-06 | Acetato de eslicarbazepina e utilização |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT111744033T PT2380573E (pt) | 2005-05-06 | 2005-05-06 | Acetato de eslicarbazepina e métodos de utilização |
Country Status (8)
Country | Link |
---|---|
EP (6) | EP2380573B1 (pt) |
JP (1) | JP2008540405A (pt) |
KR (1) | KR101236227B1 (pt) |
CN (1) | CN101217959A (pt) |
ES (2) | ES2534514T3 (pt) |
PT (2) | PT2380573E (pt) |
RU (1) | RU2010154008A (pt) |
WO (1) | WO2006121363A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
GB0700773D0 (en) * | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
US8372431B2 (en) * | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
BR112012005254A2 (pt) | 2009-09-10 | 2016-03-15 | Bial Portela & Ca Sa | formulação de suspensão oral, uso da solução de sorbitol em combinação com goma de xantano, processo para preparar uma formulação de suspensão oral compreendendo acetato de eslicarbazepina |
TR201008460A1 (tr) * | 2010-10-15 | 2012-05-21 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Eslikarbazepinin saşe formülasyonları. |
WO2013032351A1 (en) | 2011-08-26 | 2013-03-07 | BIAL - PORTELA & Cª, S.A. | Treatments involving eslicarbazepine acetate or eslicarbazepine |
US9814723B2 (en) | 2013-02-23 | 2017-11-14 | Lixin Zhang | Compositions and methods for prophylaxis and therapy for Meniere's disease |
US20140243342A1 (en) * | 2013-02-23 | 2014-08-28 | Lixin Zhang | Compositions and methods for prophylaxis and therapy for menieres disease |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
GB201306095D0 (en) * | 2013-04-04 | 2013-05-22 | Bial Portela & Ca Sa | New treatments |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT101732B (pt) * | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
US6296873B1 (en) | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
CA2463970A1 (en) * | 2001-11-12 | 2003-05-22 | Novartis Ag | Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
CN1674909A (zh) * | 2002-08-06 | 2005-09-28 | 诺瓦提斯公司 | 甲酰胺类在治疗耳鸣中的用途 |
US20040038874A1 (en) * | 2002-08-22 | 2004-02-26 | Osemwota Omoigui | Method of treatment of persistent pain |
GB0303615D0 (en) * | 2003-02-17 | 2003-03-19 | Novartis Ag | Use of organic compounds |
EP1596866A2 (en) * | 2003-02-17 | 2005-11-23 | Novartis AG | Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |
TW200502222A (en) * | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
GB2401605A (en) * | 2003-05-12 | 2004-11-17 | Portela & Ca Sa | Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof |
PE20060124A1 (es) * | 2004-03-22 | 2006-03-07 | Novartis Ag | Tabletas de desintegracion que comprenden licarbazepina |
PE20051156A1 (es) * | 2004-03-22 | 2006-02-13 | Novartis Ag | Formulaciones de matriz orales que comprenden licarbazepina |
MX2007013882A (es) * | 2005-05-06 | 2008-01-28 | Portela & Ca Sa | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. |
-
2005
- 2005-05-06 EP EP11174403.3A patent/EP2380573B1/en active Active
- 2005-05-06 PT PT111744033T patent/PT2380573E/pt unknown
- 2005-05-06 WO PCT/PT2005/000006 patent/WO2006121363A1/en active Application Filing
- 2005-05-06 JP JP2008509964A patent/JP2008540405A/ja active Pending
- 2005-05-06 ES ES11174403.3T patent/ES2534514T3/es active Active
- 2005-05-06 CN CNA2005800509788A patent/CN101217959A/zh active Pending
- 2005-05-06 EP EP11174415.7A patent/EP2380575B1/en active Active
- 2005-05-06 EP EP05740623A patent/EP1879590A1/en not_active Ceased
- 2005-05-06 ES ES11174415.7T patent/ES2534560T3/es active Active
- 2005-05-06 EP EP11174411A patent/EP2384755A1/en not_active Withdrawn
- 2005-05-06 EP EP11174413A patent/EP2386303A1/en not_active Withdrawn
- 2005-05-06 KR KR1020077028320A patent/KR101236227B1/ko active Protection Beyond IP Right Term
- 2005-05-06 EP EP11174405A patent/EP2380574A1/en not_active Withdrawn
- 2005-05-06 PT PT111744157T patent/PT2380575E/pt unknown
-
2010
- 2010-12-28 RU RU2010154008/15A patent/RU2010154008A/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EP2380575A1 (en) | 2011-10-26 |
EP2380573B1 (en) | 2015-02-25 |
EP2386303A1 (en) | 2011-11-16 |
PT2380573E (pt) | 2015-06-11 |
ES2534560T3 (es) | 2015-04-24 |
WO2006121363A1 (en) | 2006-11-16 |
EP1879590A1 (en) | 2008-01-23 |
JP2008540405A (ja) | 2008-11-20 |
EP2384755A1 (en) | 2011-11-09 |
EP2380575B1 (en) | 2015-02-25 |
EP2380573A1 (en) | 2011-10-26 |
EP2380574A1 (en) | 2011-10-26 |
ES2534514T3 (es) | 2015-04-23 |
KR101236227B1 (ko) | 2013-02-21 |
RU2010154008A (ru) | 2012-07-10 |
KR20080015429A (ko) | 2008-02-19 |
CN101217959A (zh) | 2008-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2380575E (pt) | Acetato de eslicarbazepina e utilização | |
GB0512940D0 (en) | Compounds and their use | |
IL185280A0 (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
HK1131922A1 (en) | Phenylpropionamide compounds and the use thereof | |
GB0520743D0 (en) | Compounds and their use | |
GB0516069D0 (en) | Pharmaceutical and use thereof | |
IL189252A0 (en) | Dihydroxyanthraquinones and their use | |
EP1921066A4 (en) | PYRIDYLPHENOL COMPOUND AND USE THEREOF | |
EP2069371A4 (en) | ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE | |
GB0520935D0 (en) | Integrated processor-template-system and project | |
GB0608797D0 (en) | Novel agents and the use thereof | |
ZA200709864B (en) | Eslicarbazepine acetate and methods of use | |
GB0427723D0 (en) | Compounds and their use | |
ZA200804378B (en) | Iminopropene compound and use thereof | |
GB0502843D0 (en) | Jig-was and jig-will | |
GB0513176D0 (en) | Compounds and their use | |
GB0521278D0 (en) | Compounds and their use | |
GB0517240D0 (en) | Chronorotron mk1-system and project | |
GB0522259D0 (en) | e-s-spi-l-d-film-cinema-back-engineering armageddon-system and project | |
GB0517239D0 (en) | Geogrotren-mk1-system and project | |
GB0401244D0 (en) | Compounds and their use | |
GB0410833D0 (en) | Compounds and their use | |
GB0405306D0 (en) | Compounds and their use | |
GB0407628D0 (en) | Compounds and their use | |
GB0409377D0 (en) | Compounds and their use |